Quantcast

Latest Raja M. Flores Stories

2014-08-14 23:07:07

International researchers studying a radical mesothelioma surgery say the key to survival is careful patient selection and surgical experience. Raleigh, NC (PRWEB) August 14, 2014 Research conducted at three major European and Canadian medical centers finds that the benefits of a controversial surgical procedure called extrapleural pneumonectomy (EPP) can outweigh the risks for mesothelioma patients, under the right conditions. Click here to read the full story, just posted on the...

2014-08-11 08:28:38

TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, announced today that its subsidiary Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, enrolled the first patients in a randomized Phase 2 trial to evaluate...

2014-08-07 23:06:21

Researchers comparing the mesothelioma biomarkers mesothelin and fibulin-3 say mesothelin is still the most effective marker for diagnosis but fibulin-3 has another use. Raleigh, NC (PRWEB) August 07, 2014 Scientists in Australia have just released the results of an important report comparing the relative values of the protein biomarkers mesothelin and fibulin-3 in the management of malignant pleural mesothelioma. Surviving Mesothelioma has just posted a new article on the study. Click...

2014-08-06 23:07:01

UK researchers say it may be time to “re-evaluate” the reliance on CT scans to determine which suspected pleural cancer patients should get biopsies. Raleigh, NC (PRWEB) August 06, 2014 Scientists at two tertiary referral centers are suggesting that CT scans may not be accurate enough as a means of deciding whether to perform a surgical biopsy in patients with a suspected pleural cancer like mesothelioma. Click here to read Surviving Mesothelioma’s newly-posted article on the study....

2014-08-04 23:07:06

Italian researchers say a molecule linked with ovarian cancer may also affect the aggressiveness of malignant pleural mesothelioma. Raleigh, NC (PRWEB) August 04, 2014 Scientists studying a call surface protein called CD157 say it can impact multiple aspects of mesothelioma – from how fast it grows to how easily it spreads – and may even affect chemotherapy response. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now. Researchers at the...

2014-07-30 23:08:18

New research suggests that the blood protein albumin may offer a simple, fast way to predict treatment response in people with malignant pleural mesothelioma. Raleigh, NC (PRWEB) July 30, 2014 Chinese researchers say a protein that makes up about 60% of protein mass in blood plasma can be used as a prognostic indicator in people on chemotherapy for malignant pleural mesothelioma. Click here to read the full article on the study, just posted on the Surviving Mesothelioma website....

2014-07-28 23:07:38

Japanese researchers report good results with a new, more sensitive test for a key mesothelioma biomarker. Raleigh, NC (PRWEB) July 28, 2014 Scientists in Japan have completed initial tests of what they say is an improved blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now. Researchers in the Department of Respiratory Medicine at Tokyo’s Juntendo University Graduate School of Medicine say a new...

2014-07-14 23:06:45

If an NIH grant can help validate the effectiveness of photodynamic therapy (PDT), more mesothelioma patients may have access to it in the future. Raleigh, NC (PRWEB) July 14, 2014 The NIH is giving $8 million dollars to researchers at the University of Pennsylvania to fund a clinical trial on light-based therapy in mesothelioma surgical patients. Click here to read Surviving Mesothelioma’s newly-posted article on the research. Scientists at the University of Pennsylvania plan to use...

2014-07-11 23:05:26

Scientists say slight inherited differences in the genes may help predict how mesothelioma patients will respond to chemotherapy. Raleigh, NC (PRWEB) July 11, 2014 Cancer researchers in Slovenia say genetic variations called polymorphisms appear to have a significant impact on how patients respond to treatment with pemetrexed (Alimta), the most popular chemotherapy drug for mesothelioma. Surviving Mesothelioma has the full story. Click here to read the new post now. Researchers at the...

2014-07-08 23:09:40

Top mesothelioma researchers say an immunotoxin may have the power to significantly improve the effectiveness of chemotherapy in patients with malignant pleura mesothelioma. Raleigh, NC (PRWEB) July 08, 2014 According to a new NIH research study, more than three quarters of mesothelioma patients responded to chemotherapy when they were also given the anti-mesothelin immunotoxin SS1P. Click here to read Surviving Mesothelioma’s newly-posted article on how this important study may impact...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related